[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367442-105":59,"doc-detail-367442-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","prognostic-impact-of-serum-interleukin-6-and-17-level-in-patients-with-bladder-cancer-a-systematic-review-and-meta-analysis","Prognostic impact of serum interleukin-6 and 17 level in patients with bladder cancer - a systematic review and meta-analysis","","Background: Interleukin functions as a noninvasive biomarker with major potential to inform management of inflammatory and cancer conditions. This systematic review and meta-analysis assessed the prognostic role of interleukin in bladder cancer (BCa). Methods: Searches across PubMed, Embase, Web of Science, CNKI, Wanfang, and Chinese Biomedical Literature Service System were performed from inception to July 10, 2024. Outcome measures included DFS, OS, and DSS. Results: Seven studies (1,505 patients) were included. Elevated serum IL levels were linked to worse OS and poorer DFS, while DSS showed no significant association. Conclusion: Serum interleukin levels are strongly associated with survival outcomes in BCa.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-impact-of-serum-interleukin-6-and-17-level-in-patients-with-bladder-cancer-a-systematic-review-and-meta-analysis/367442/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-impact-of-serum-interleukin-6-and-17-level-in-patients-with-bladder-cancer-a-systematic-review-and-meta-analysis/367442.png","ImageObject",300,407,{"name":92,"@type":93},"Sophia Brooks","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of the systematic review and meta-analysis?","Question",{"text":113,"@type":114},"To evaluate the prognostic role of interleukin levels in bladder cancer patients, focusing on survival outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which databases were searched and what was the search period?",{"text":118,"@type":114},"Six English and Chinese databases (PubMed, Embase, Web of Science, CNKI, Wanfang, and Chinese Biomedical Literature Service System) were searched from inception to July 10, 2024.",{"name":120,"@type":111,"acceptedAnswer":121},"How were survival outcomes defined in the analysis?",{"text":122,"@type":114},"Outcome measures included disease-free survival (DFS), overall survival (OS), and disease-specific survival (DSS).",{"name":124,"@type":111,"acceptedAnswer":125},"What did the results show regarding OS, DFS, and DSS?",{"text":126,"@type":114},"Elevated serum interleukin levels were associated with worse OS and poorer DFS. Only limited evidence was available for DSS, and no significant association was found.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},367442,1790722588,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Submitted 28 October 2024 Accepted 7 April 2025  \nPublished 29 April 2025 Corresponding author Liang Liu, [mnwkll@163.com](mnwkll@163.com)  \nAcademic editor Hilal Ozdag Sevgili  \nAdditional Information and Declarations can be found on page 14  \nDOI 10.7717/peerj.19385  \nCopyright 2025 Liu et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nPrognostic impact of serum interleukin-6 and 17 level in patients with bladder cancer: a systematic review and  \nmeta-analysis  \nLiang Liu 1,2,3, Jun-Hui He4, Yu Xiao5 and Dong Wei6  \n1 Department of Urology, Baoding No. 1 Central Hospital, Baoding, Hebei, China  \n2 Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor in Hebei Province, Baoding, Hebei, China  \n3 Prostate and Andrology Key Laboratory of Baoding, Baoding, Hebei, China  \n4 Department of Urology, Heze Municipal Hospital, Heze, Shandong, China  \n5 Psychosomatic Medical Center, The Fourth People’s Hospital of Chengdu, Chengdu, Sichuan, China  \n6 Department of Urology, Hebei General Hospital, Shijiazhuang, Hebei, China  \nABSTRACT  \nBackground: Interleukin, a noninvasive biomarker, holds huge potential for providing valuable insights into the management of inﬂammatory conditions and tumor diseases. This systematic review and meta-analysis aimed to evaluate the prognostic role of interleukin in bladder cancer (BCa) patients.  \nMethods: A comprehensive search of six English and Chinese databases (PubMed, Embase, Web of Science, Chinese National Knowledge Infrastructure (CNKI), Wanfang, and Chinese Biomedical Literature Service System) was conducted from inception to July 10, 2024 . Studies investigating the association between serum interleukin levels and BCa were included. Outcome measures encompassed disease-free survival (DFS), overall survival (OS), and disease-speciﬁc survival (DSS) . Statistical analyses were performed using RevMan 5.4.1, employing random or ﬁxed-effects models as appropriate. Sensitivity, subgroup, and descriptive analyses were also conducted.  \nResults: A total of seven studies involving 1,505 patients were included. Four studies reported the association between serum interleukin-6/17 (IL-6/17) and OS in BCa. Patients with elevated serum IL levels exhibited a worse OS (HR = 2.28; 95% CI [1.03–5.05]; P = 0.04); however, subgroup analysis revealed that only high serum IL- 17 levels were signiﬁcantly associated with shorter OS, while IL-6 levels showed no association with OS. Six studies examined the relationship between serum IL-6/17 and DFS in BCa. Patients with elevated serum IL levels were associated with poorer DFS (HR = 2 .57; 95% CI [1 .55–4.26]; P \u003C 0 .001) . This association remained consistent across subgroup analyses based on interleukin type, publication country, and surgical methods. Only two studies investigated the relationship between serum IL-6/17 and DSS in BCa, with no signiﬁcant association found (HR = 1.58; 95% CI [1 .00-2.51]; P = 0 .05) .  \nConclusion: This meta-analysis demonstrates a strong association between serum interleukin levels and survival outcomes in BCa, suggesting that serum interleukin  \nHow to cite this article Liu L, He J, Xiao Y, Wei D. 2025. Prognostic impact of serum interleukin-6 and 17 level in patients with bladder cancer: a systematic review and meta-analysis. PeerJ 13:e19385 DOI 10.7717/peerj.19385  \ntesting may be a valuable clinical tool for predicting patient outcomes and guiding treatment decisions.  \nSubjects Immunology, Oncology, Urology  \nKeywords Urinary bladder neoplasms, Bladder cancer, Interleukin-6, Interleukin-17, Metaanalysis, Systematic review  \nINTRODUCTION  \nBladder cancer (BCa) is classiﬁed into non-muscle invasive and muscle-invasive subtypes and ranks as the tenth most common cancer globally, characterized by high mortality and recurrence rates (Richters, Aben & Kiemeney, 2019) . It is reported that 25% of newly diagnosed BCa cases involve muscle-invasive or metastatic disease (Kamat et al., 2016) . The prognostication of BCa h","cbCaijSmmylvskbs","https://ap.wps.com/l/cbCaijSmmylvskbs","pdf",11407028,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the purpose of the systematic review and meta-analysis?\",\"answer\":\"To evaluate the prognostic role of interleukin levels in bladder cancer patients, focusing on survival outcomes.\"},{\"question\":\"Which databases were searched and what was the search period?\",\"answer\":\"Six English and Chinese databases (PubMed, Embase, Web of Science, CNKI, Wanfang, and Chinese Biomedical Literature Service System) were searched from inception to July 10, 2024.\"},{\"question\":\"How were survival outcomes defined in the analysis?\",\"answer\":\"Outcome measures included disease-free survival (DFS), overall survival (OS), and disease-specific survival (DSS).\"},{\"question\":\"What did the results show regarding OS, DFS, and DSS?\",\"answer\":\"Elevated serum interleukin levels were associated with worse OS and poorer DFS. Only limited evidence was available for DSS, and no significant association was found.\"}]","Prognostic impact of serum interleukin-6 and 17 level in patients with bladder cancer - a systematic review and meta-analysis | PDF",1790170818,45,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad48221048719767eea0ea04fb4737a2.webp",983,1272,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de9e082299a48d866add29894e463ecd.webp",982,1270,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/944e44cec0499c05abee324980011424.webp",981,1269,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/977edeae78540a09c4c3376a4c93b33e.webp",980,1268]